FDA Warns Pradaxa May Lead to Severe Internal Bleeding or Heart Failure
The Safety Communication in the U.S. Food and Drug Administration (FDA) issued a warning on December 7, 2011 that the anti-clotting drug Pradaxa can lead to severe, if not fatal, internal bleeding. According to the FDA's warning, Pradaxa may be likely to cause serious internal bleeding or heart failure that in some cases lead to death.
“We have noted on multiple occasions patients who have been ‘bleeding out’ from Pradaxa and our hands are tied,” says Dr. Bryan Cotton of the Center for Translational Injury Research in Houston, Texas. “They’re bleeding out all over and there’s absolutely nothing we can do about it. I’m helpless when it comes into my emergency room.”
With more than 2.6 million Americans diagnosed with Atrial fibrillation, the anti-coagulant drug Pradaxa was prescribed to a great number of Americans to reduce the risk of stroke. The FDA, however, found that the drug may do more damage than good in the December 2011 Safety Communication on Pradaxa. The document reported that of the estimated 371,000 Pradaxa users, 1583 reported gastrointestinal hemorrhage and 466 reported vascular hemorrhage. Fortunately for individuals who have been prescribed Pradaxa, the Pradaxa Lawsuit Center website provides essential information to help gauge their options.
The comprehensive website, http://www.pradaxalawsuitcenter.com, provides answers about heart attack and internal bleeding risks, as well as answers to liability questions that apply to most Pradaxa claims. Additionally, the Pradaxa Lawsuit Center website offers free, no-obligation Pradaxa case reviews to interested parties. While visiting the website, patients have the opportunity to ask professionals any questions about their individual situation and receive an initial personal consultation at no cost. Attorneys representing Pradaxa victims across the country are standing by, available to chat live to answer any questions a patient may have.
“These additional concerns deserve serious consideration in weighing the risks and benefits of [Pradaxa],” said Archives of Internal Medicine editor Rita Redberg, MD.
For more information about Pradaxa risks and lawsuits, including how to contact a Pradaxa lawyer, please visit http://www.pradaxalawsuitcenter.com/.